Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;134(4):491-492.
doi: 10.1016/j.anai.2025.01.008.

Authors' response

Rory Chan  1 , Carlo Lombardi  2 , Pasquale Comberiati  3 , Alvise Berti  4 , Francesco Menzella  5 , Ronald J Dandurand  6 , Zuzana Diamant  7 , Marcello Cottini  8
Affiliations

Authors' response

Rory Chan et al. Ann Allergy Asthma Immunol. 2025 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Chan reports receiving an institutional grant from Chiesi; serving on the advisory boards for AstraZeneca; receiving personal fees (talks) from AstraZeneca, Chiesi, and Thorasys; receiving support for attending meetings from AstraZeneca, Chiesi, NIOX, and Sanofi-Regeneron; and receiving honoraria (drafting educational material) from AstraZeneca and Vitalograph. Dr Menzella reports receiving research grants from AstraZeneca, Sanofi, Glaxo-Smith-Kline, and Chiesi Farmaceutici and lecture fees and advisory board fees from AstraZeneca, Chiesi Farmaceutici, GlaxoSmithKline, and Lusofarmaco. Dr Dandurand reports receiving investigator-initiated study grants from AstraZeneca and Boehringer Ingelheim and unrestricted grants from Thorasys. Prof Diamant reports receiving consulting fees and/or payments for lectures in the past 3 years from Arcede, Biosion, Foresee Pharmaceuticals, Cascador/Galenusheath, GlaxoSmithKline, Hippo-Dx, Pleuran, Sanofi-Genzyme, and QPS-NL; having leadership role in EUFOREA (asthma expert panel chair 2020-2024); and having associate editorships at Springer (Resni/MedNet 2011-2024), Allergy (2018-2024), and Respiratory Medicine (2004-ongoing). The remaining authors have no conflicts of interest to report.

LinkOut - more resources